Johnson & Johnson (NYSE:JNJ) Earns “Buy” Rating from Royal Bank of Canada

Share on StockTwits

Johnson & Johnson (NYSE:JNJ)‘s stock had its “buy” rating reiterated by Royal Bank of Canada in a research report issued on Tuesday, Borsen Zeitung reports.

A number of other brokerages also recently issued reports on JNJ. Goldman Sachs Group set a $27.00 price target on shares of Melco Resorts & Entertainment and gave the company a “buy” rating in a report on Tuesday, May 28th. Morgan Stanley set a $60.00 price objective on shares of Berry Global Group and gave the stock a “hold” rating in a report on Wednesday, April 17th. Raymond James set a $8.00 price objective on shares of Superior Energy Services and gave the stock a “buy” rating in a report on Wednesday, April 17th. Zacks Investment Research raised shares of Jack Henry & Associates from a “sell” rating to a “hold” rating in a report on Wednesday, March 27th. Finally, BMO Capital Markets assumed coverage on shares of Yelp in a report on Wednesday, April 17th. They issued an “outperform” rating on the stock. Four equities research analysts have rated the stock with a hold rating and nine have issued a buy rating to the stock. Johnson & Johnson presently has a consensus rating of “Buy” and a consensus price target of $150.33.

Shares of NYSE JNJ opened at $131.86 on Tuesday. The company’s 50-day moving average is $138.32. The company has a debt-to-equity ratio of 0.47, a quick ratio of 1.13 and a current ratio of 1.44. The stock has a market cap of $351.79 billion, a P/E ratio of 15.23, a PEG ratio of 2.29 and a beta of 0.70. Johnson & Johnson has a 52-week low of $121.00 and a 52-week high of $148.99.

Johnson & Johnson (NYSE:JNJ) last announced its quarterly earnings results on Tuesday, July 16th. The company reported $2.58 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.42 by $0.16. The firm had revenue of $20.56 billion for the quarter, compared to the consensus estimate of $20.39 billion. Johnson & Johnson had a net margin of 20.08% and a return on equity of 38.57%. The business’s quarterly revenue was down 1.3% compared to the same quarter last year. During the same quarter last year, the firm posted $2.10 EPS. As a group, equities research analysts forecast that Johnson & Johnson will post 8.59 EPS for the current fiscal year.

In other Johnson & Johnson news, Director Marillyn A. Hewson acquired 3,000 shares of the company’s stock in a transaction that occurred on Tuesday, June 11th. The shares were bought at an average price of $139.68 per share, with a total value of $419,040.00. Following the completion of the acquisition, the director now owns 3,000 shares in the company, valued at approximately $419,040. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Company insiders own 0.23% of the company’s stock.

Several institutional investors and hedge funds have recently bought and sold shares of JNJ. Thoroughbred Financial Services LLC lifted its holdings in Johnson & Johnson by 14,147.0% during the second quarter. Thoroughbred Financial Services LLC now owns 4,014,247 shares of the company’s stock valued at $401,425,000 after purchasing an additional 3,986,071 shares in the last quarter. Vanguard Group Inc lifted its holdings in Johnson & Johnson by 1.5% during the third quarter. Vanguard Group Inc now owns 213,433,449 shares of the company’s stock valued at $29,490,100,000 after purchasing an additional 3,235,861 shares in the last quarter. Nordea Investment Management AB lifted its holdings in Johnson & Johnson by 14.2% during the first quarter. Nordea Investment Management AB now owns 8,709,414 shares of the company’s stock valued at $1,217,494,000 after purchasing an additional 1,079,751 shares in the last quarter. Mn Services Vermogensbeheer B.V. lifted its holdings in Johnson & Johnson by 152.1% during the fourth quarter. Mn Services Vermogensbeheer B.V. now owns 1,083,996 shares of the company’s stock valued at $122,372,000 after purchasing an additional 654,085 shares in the last quarter. Finally, Royal London Asset Management Ltd. lifted its holdings in Johnson & Johnson by 53.2% during the fourth quarter. Royal London Asset Management Ltd. now owns 1,869,313 shares of the company’s stock valued at $199,471,000 after purchasing an additional 648,775 shares in the last quarter. 66.85% of the stock is currently owned by institutional investors.

About Johnson & Johnson

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the health care field worldwide. It operates in three segments: Consumer, Pharmaceutical, and Medical Devices. The Consumer segment offers baby care products under the JOHNSON'S brand; oral care products under the LISTERINE brand; beauty products under the AVEENO, CLEAN & CLEAR, DABAO, JOHNSON'S Adult, LE PETITE MARSEILLAIS, NEUTROGENA, and OGX brands; over-the-counter medicines, including acetaminophen products under the TYLENOL brand; cold, flu, and allergy products under the SUDAFED brand; allergy products under the BENADRYL and ZYRTEC brands; ibuprofen products under the MOTRIN IB brand; and acid reflux products under the PEPCID brand.

Recommended Story: How does a 12b-1 fee affect fund performance?

Analyst Recommendations for Johnson & Johnson (NYSE:JNJ)

Receive News & Ratings for Johnson & Johnson Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Johnson & Johnson and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Continental Resources, Inc.  Given Consensus Recommendation of “Buy” by Brokerages
Continental Resources, Inc. Given Consensus Recommendation of “Buy” by Brokerages
Bruker Co.  Receives $49.20 Consensus Price Target from Analysts
Bruker Co. Receives $49.20 Consensus Price Target from Analysts
Rio Tinto plc ADR  Receives Average Rating of “Hold” from Brokerages
Rio Tinto plc ADR Receives Average Rating of “Hold” from Brokerages
Crescent Point Energy Corp  Receives Average Recommendation of “Buy” from Analysts
Crescent Point Energy Corp Receives Average Recommendation of “Buy” from Analysts
Eastgroup Properties Inc  Given Consensus Recommendation of “Hold” by Brokerages
Eastgroup Properties Inc Given Consensus Recommendation of “Hold” by Brokerages
Brokerages Set Canadian National Railway  Price Target at C$125.09
Brokerages Set Canadian National Railway Price Target at C$125.09


© 2006-2019 Ticker Report